who puts thumbs down when they should be listening. Insmed already knows the NTM results and is planning the phase 3 trial.It will take 3 + years to get it to market if all goes well but that does not usually happen in bio.
You have no idea if Insmed knows the NTM results and, indeed, it is very unlikely that Insmed knows the results since they are not likely to be released until February or March. If you have information that proves Insmed has the results, post it. But, of course, you won't because you are either a paid basher or an idiot.
And in terms of Insmed planning a Phase 3 trial for NTM, this is another fabrication. If you go to the Insmed corporate website and if you are intelligent enough to find the November 2013 Investor Presentation, you will see that Insmed expects to have "approval and launch" of Arikace for both NTM (U.S.) and CF (EU) in the first half of 2015.
I can not post information through the grapevine but Insmed has known after the first 3 months that they would need cash for a Phase3 trial.
So they raised a lot of it.
Why was that when they had stated cash was not needed if results had been good and could easily have gotten a partner to finance launch.You will see.